Comanche Biopharma Corp.

About Comanche Biopharma Corp.

Comanche Biopharma is a biopharmaceutical company dedicated to making every pregnancy safer worldwide. Their mission is to develop and globally provide the first therapy targeting a root cause of preeclampsia, envisioning a world where all women and babies have access to safe, effective, evidence-based, and affordable therapies for life-threatening pregnancy complications.

Products & Services

Investigational siRNA Medicine:A therapy under development for treating preterm preeclampsia, aimed at addressing a root cause of the condition.

Specialties

siRNA medicine development Preterm preeclampsia treatment Pregnancy complication therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 75000000 MR: - FA: $75 million FAN: 75000000	D: 2024-01-17 FD: 2024-01-17	6 investors

Series B Latest

2024-01-17

$75.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Ann Taylor

M.D.

A

Allyson Felix

Olympic athlete

Recent News